Anavex Life Sciences Corp (AVXL)

[Steady_T]

I also found it interesting that Fragile X is going to be a pivotal study. AFAIK there hasn't been a P2 Fragile X study, so this one is going straight to pivotal. Same for the unnamed rare disease.

With the Rett pediatric trial that is the three pivotal trials. Nice.

6:10 into the presentation.

As they say...three shots on goal.

Also Missling again pointed out that the PDD data showed positive dose related effects in PDD that is also a primary end point in the AD 450 subject trial. That is a big deal.